Copyright
©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 571-583
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.571
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.571
Characteristics | Values |
Age | 50.1 (14-82) |
Male sex, % | 54.6 |
Body mass index, kg/m2 | 26.9 (20.8-49.5) |
Fibrosis stage, 0/1/2/3/4 | 65/173/111/122/18 |
Grade, 0/1/2/3 | 45/204/178/62 |
Steatosis, 0/1/2/3 | 13/158/228/90 |
NAFLD activity score, < 4/≥ 5 | 265/224 |
ALT, IU/L | 69 (2-563) |
AST, IU/L | 43 (13-312) |
γ-GTP, IU/L | 60 (12-736) |
Total bilirubin, mg/dL | 0.8 (0.04-2.7) |
Total cholesterol, ng/dL | 198 (102-317) |
Cholinesterase, IU/L | 205 (90-337) |
Platelet count, × 104/μL | 20.8 (6.6-44.7) |
Albumin, g/dL | 4.5 (2.5-5.4) |
HOMA-IR | 2.9 (0.7-22.4) |
Iron, μg/dL | 119 (13-295) |
Ferritin, ng/dL | 149 (3.9-983) |
Leptin, ng/dL | 9.3 (1.1-59.3) |
Adiponectin, μg/mL | 5.5 (2.0-27.5) |
High-sensitivity CRP, mg/dL | 0.117 (0.01-1.92) |
P-III-P, U/mL | 0.7 (0.28-3.8) |
Type IV collagen 7S, ng/mL | 4.1 (1.9-15) |
Hyaluronic acid, ng/mL | 28 (9-619) |
Fibrosis-4 index | 1.29 (0.17-1.29) |
n (%) | |
All deaths | 13 (2.7) |
Liver-related events | 7 (1.4) |
HCC + liver failure | 3 |
HCC only | 1 |
Liver failure | 3 |
Cerebrovascular disease | 1 (0.2) |
Non-liver cancers | 4 (0.8) |
Pancreatic cancer | 2 |
Bile duct cancer | 2 |
Infection | 1 (0.2) |
AUROC | Odds ratio | 95%CI | P value | |
AST | 0.57 | 1.00 | 0.99-1.02 | 0.9841 |
ALT | 0.71 | 0.97 | 0.95-0.99 | 0.0026 |
γ-GTP | 0.521 | 1.00 | 0.99-1.01 | 0.4259 |
Platelet count | 0.748 | 0.78 | 0.69-0.88 | < 0.0001 |
Total bilirubin | 0.588 | 1.10 | 0.55-1.39 | 0.3208 |
Total cholesterol | 0.580 | 0.99 | 0.98-1.01 | 0.2 |
Iron | 0.553 | 1.01 | 1.02 | 0.1801 |
Albumin | 0.815 | 0.093 | 0.04-0.20 | < 0.0001 |
Ferritin | 0.527 | 1.00 | 1.00-1.00 | 0.7651 |
Leptin | 0.565 | 1.00 | 0.94-1.06 | 0.7441 |
HOMA-IR | 0.731 | 1.04 | 1.009-1.06 | 0.0182 |
P-III-P | 0.786 | 5.58 | 2.27-11.6 | 0.0014 |
Type IV collagen 7S | 0.863 | 1.48 | 1.28-1.67 | < 0.0001 |
Fibrosis-4 index | 0.914 | 1.799 | 1.44-2.23 | < 0.0001 |
- Citation: Kawanaka M, Nishino K, Ishii K, Tanikawa T, Urata N, Suehiro M, Sasai T, Haruma K, Kawamoto H. Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease. World J Hepatol 2021; 13(5): 571-583
- URL: https://www.wjgnet.com/1948-5182/full/v13/i5/571.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i5.571